Revenio Group Corporation: EMPLOYER-EMPLOYEE NEGOTIATIONS REGARDING REVENIO'S RIB BUSINESS CONCLUDED


Revenio Group Corporation    Stock Exchange Release         September 9 2014 at
9:00 AM

EMPLOYER-EMPLOYEE NEGOTIATIONS REGARDING REVENIO'S RIB BUSINESS CONCLUDED

The employer-employee negotiations within Boomeranger Boats Ltd., a company
specializing in Rigid Inflatable Boats (RIB) which is part of the Technology and
Services business segment of the Finnish health tech group Revenio Group
Corporation, have been concluded. The negotiations have implications on the
entire personnel of Boomeranger Boats Ltd., approximately 27 persons in total.

As a result of the negotiations, the company will be able to implement any
necessary fixed-term layoffs and staffing reductions as of 15 October 2014. The
extent of the layoffs will depend on how the company's order book develops.

The aim of the layoffs agreed in the course of the negotiations is to adjust the
company's cost structure to its changed operating environment, which currently
poses some challenges. The layoffs will be carried out in preparation for a
potential scenario in which the existing, substantial order book of Boomeranger
Boats Ltd. cannot be fully realized. The risk of this is caused by the general
economic situation, which has been noted to hinder decision-making processes.
Another goal of the negotiations is to ensure that the profitability trend of
Revenio Group Corporation continues in line with its strategy.

For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi


The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy. The widely patented Icare product family is the current cornerstone of the
Group's success. Revenio seeks vigorous growth in health technology, both
organically and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry.

In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.




[HUG#1854423]